Skip to Content

Cellular Immunotherapy for Cancer Meeting Materials

Main Content

The Cellular Immunotherapy for Cancer Working Committee provides scientific oversight for studies related to the utilization and outcomes after CAR-T cell therapies and other cellular immunotherapies. Studies that focus on specific outcomes, a predictor of outcomes, and utilization of CAR-T cells should be submitted to this committee.

Meetings are held annually during the Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR. Anyone with interest or expertise in the focus area is encouraged to attend.